Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7482997rdf:typepubmed:Citationlld:pubmed
pubmed-article:7482997lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:7482997lifeskim:mentionsumls-concept:C0439590lld:lifeskim
pubmed-article:7482997lifeskim:mentionsumls-concept:C2911684lld:lifeskim
pubmed-article:7482997lifeskim:mentionsumls-concept:C0086315lld:lifeskim
pubmed-article:7482997lifeskim:mentionsumls-concept:C0185117lld:lifeskim
pubmed-article:7482997pubmed:issue9lld:pubmed
pubmed-article:7482997pubmed:dateCreated1995-12-4lld:pubmed
pubmed-article:7482997pubmed:abstractTextThe AP-1 transcription factors are composed of the Fos and Fos-related antigens as well as Jun and related proteins. These factors have been extensively studied in many diverse paradigms using acute stimuli. Recent attention has focussed on long-term elevation of Fos-related antigens in the CNS, and this is discussed by Keith Pennypacker, Jau-S. Hong and Michael McMillian. Repeated or chronic treatment elevates Fos-related antigen levels for days in many different brain regions. Both direct and indirect stimulation are responsible for the protracted increase in Fos-related antigen-immunoreactive proteins, which may modulate late onset genes involved in neuroplasticity. Understanding the role of these factors in long-lasting or permanent disease states may provide insight into potential therapeutic strategies to treat chronic CNS disorders.lld:pubmed
pubmed-article:7482997pubmed:languageenglld:pubmed
pubmed-article:7482997pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7482997pubmed:citationSubsetIMlld:pubmed
pubmed-article:7482997pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7482997pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7482997pubmed:statusMEDLINElld:pubmed
pubmed-article:7482997pubmed:monthSeplld:pubmed
pubmed-article:7482997pubmed:issn0165-6147lld:pubmed
pubmed-article:7482997pubmed:authorpubmed-author:HongJ SJSlld:pubmed
pubmed-article:7482997pubmed:authorpubmed-author:PennypackerK...lld:pubmed
pubmed-article:7482997pubmed:authorpubmed-author:McMillianM...lld:pubmed
pubmed-article:7482997pubmed:issnTypePrintlld:pubmed
pubmed-article:7482997pubmed:volume16lld:pubmed
pubmed-article:7482997pubmed:ownerNLMlld:pubmed
pubmed-article:7482997pubmed:authorsCompleteYlld:pubmed
pubmed-article:7482997pubmed:pagination317-21lld:pubmed
pubmed-article:7482997pubmed:dateRevised2005-11-16lld:pubmed
pubmed-article:7482997pubmed:meshHeadingpubmed-meshheading:7482997-...lld:pubmed
pubmed-article:7482997pubmed:meshHeadingpubmed-meshheading:7482997-...lld:pubmed
pubmed-article:7482997pubmed:meshHeadingpubmed-meshheading:7482997-...lld:pubmed
pubmed-article:7482997pubmed:meshHeadingpubmed-meshheading:7482997-...lld:pubmed
pubmed-article:7482997pubmed:meshHeadingpubmed-meshheading:7482997-...lld:pubmed
pubmed-article:7482997pubmed:meshHeadingpubmed-meshheading:7482997-...lld:pubmed
pubmed-article:7482997pubmed:meshHeadingpubmed-meshheading:7482997-...lld:pubmed
pubmed-article:7482997pubmed:year1995lld:pubmed
pubmed-article:7482997pubmed:articleTitleImplications of prolonged expression of Fos-related antigens.lld:pubmed
pubmed-article:7482997pubmed:affiliationDepartment of Pharmacology and Therapeutics, University of South Florida, Tampa 33612-4799, USA.lld:pubmed
pubmed-article:7482997pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7482997pubmed:publicationTypeReviewlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7482997lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7482997lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7482997lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7482997lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7482997lld:pubmed